Serum Levels of Fibrin/Fibrinogen Degradation
Products in the HaemolyticUraemic Syndrome
The phenomenon of intravascular coagulation is becoming increasingly recognized as having an important part, primarily or secondarily, in the pathogenesis of a wide variety of disease states. Abildgaard (1969) has recently reviewed such conditions, and of the instances he gave, the haemolytic-uraemic syndrome of Gasser appears to provide a classic example of intravascular coagulation, as suggested by Piel and Phibbs (1966) .
One of the most useful methods of detecting the existence of even low-grade intravascular coagulation is the quantitative estimation of degradation products of fibrin/fibrinogen (FDP) which may also be used as an index of progress and response to treatment.
Normal values of serum FDP are already known both for children (Uttley, Allan, and Cash, 1969) and for adults (Das et al., 1967) , as measured by the tanned red cell haemagglutination inhibition immunoassay. We have been able to study serum FDP from an early stage in the presentation of a case of the haemolytic-uraemic syndrome and subsequently to follow progress during treatment with heparin.
Case Report A child aged 21 months presented after the sudden onset of pallor in association with irritability and listlessness. For 2 weeks previously he had had mild diarrhoea. Shortly before his admission his mother had noticed transient jaundice, easy bruising, and a haemorrhagic rash. After a normal birth, this child had continued to develop satisfactorily and suffered no significant illnesses. There was no history of hereditary disease nor of renal disease in his family.
Examination confirmed the pallor and petechial rash with a positive Hess test. Jaundice was no longer detectable but several large bruises persisted. His blood pressure was 130/90 mm. Hg. No further clinical abnormalities were noted.
Laboratory results. Renal involvement was confirmed by the finding of protein + + +, red blood cells, and casts in the urine, the 24-hour volume of which was only 300 ml. on the first day. Blood urea nitrogen was 51 mg./100 ml. and serum K 4-1 mEq/l. Initial creatinine clearance gave a value of 17*7 ml./min.
(62-0 ml./min. per 1-73 sq. m.). Urine culture was negative throughout. Hb was 6-4 g./100 ml., PCV 20%, WBC 7200, reticulocytes 10%, ESR 25 mm./hr., and platelets 81,000/cu. mm. The film showed the marked fragmentation of red blood cells and the burr cell formation typical of this syndrome.
While clotting and bleeding times were normal and the thrombin clotting time 13-5 sec. (control 12-0), serum FDP was 512 ,ug./ml. (normal 10-9 ± 4 7) (Uttley et al., 1969) . Plasma fibrinogen was normal. Factor VIII activity was 160%. Plasma haemoglobin was 48*5 mg./ 100 ml., and haptoglobins were absent. Urinary haemosiderin was present as was urobilinogen.
Treatment and progress. Heparin therapy was initiated with a dose of 500 I.U., and continued with the constant intravenous infusion of 1500 I.U. daily. A transfusion of 250 ml. whole blood was given on the second day. Pertinent data are shown in Fig. Over-all clotting status was monitored by daily thrombin clotting times, with and without protamine titration but never became abnormal.
Dietary salt intake was initially restricted until diuresis occurred on the eighth day. Heparin therapy was continued until all the clinical and laboratory findings had returned to normal. The most persistent abnormality was fragmentation of the red cells on the blood film. 
Comments
It has been felt for some years (Abildgaard, 1969; Piel and Phibbs, 1966) Monnens and Schretlen (1967) and quantitated at a level of 140 ,zg./ml. in one of the cases of Brain et al. (1968) , later rising to about 300 ,tg./ml. The failure to show pretreatment depletion of consumable clotting factors such as factor VIII and fibrinogen has also been noted in most cases reported before, and gives support to the possibility that the haemolytic-uraemic syndrome represents localized (renal) intravascular coagulation rather than the disseminated phenomenon (Gilchrist et al., 1969) .
The finding and quantitation of raised serum FDP confirms the presence of either localized or disseminated intravascular coagulation, and indicates the need for anticoagulation.
The results of heparin therapy have been reviewed by Brain et al. (1968) . In view of the known history of the disease, it cannot be claimed that the satisfactory outcome of this particular case is directly related to the heparin given. Its interest, however, lies in the demonstration of the value of the detection and serial estimation of serum FDP as an extremely sensitive measurement of abnormality in the initial diagnosis and subsequent therapeutic management.
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